PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808923
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1808923
Sternal Closure Systems Market size was valued at US$ 2,876.87 Million in 2024, expanding at a CAGR of 5.8% from 2025 to 2032.
The Sternal Closure Systems Market includes devices used to stabilize and close the sternum after procedures like coronary artery bypass grafting (CABG). Over 900,000 open-heart surgeries are performed annually in the U.S. and Europe, driving demand for advanced closure methods. Rigid fixation systems such as plates and screws are gaining traction due to reduced complications versus traditional wires. Innovations like bioabsorbable materials and 3D-printed implants are enhancing surgical outcomes. However, high costs, long training periods, and infection risks present ongoing challenges. Despite this, rising cardiovascular disease cases and the adoption of minimally invasive surgeries continue to create opportunities.
Sternal Closure Systems Market- Market Dynamics
Growing Cardiac Surgery Volume and Technological Advancements Propel Demand for Sternal Closure Systems
The increasing global burden of cardiovascular disease is significantly boosting the demand for sternal closure systems, especially as the number of open-heart surgeries continues to climb. According to the World Health Organization, over 17.9 million people die annually from cardiovascular conditions, accounting for 32% of all global deaths. As a result, the need for reliable post-sternotomy stabilization is rising. Advanced systems like rigid plate fixation and biocompatible materials are gaining traction for reducing post-operative complications such as mediastinitis. The U.S. FDA has approved multiple innovative sternal closure devices in the last two years, indicating strong regulatory momentum. In 2023, DePuy Synthes expanded its titanium-based sternal fixation product line to support complex cardiac cases, while Zimmer Biomet collaborated with major U.S. hospitals to implement enhanced recovery protocols incorporating its sternal closure solutions. These advancements are reshaping perioperative care and improving recovery timelines.
Sternal Closure Systems Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.8% over the forecast period (2025-2032)
Based on product type segmentation, Closure devices were predicted to show maximum market share in the year 2024
Based on Material segmentation, Titanium alloys were the leading Material in 2024
Based on Fixation Type segmentation, Rigid Fixation was the leading Fixation Type in 2024
Based on Application segmentation, Coronary Artery Bypass Grafting (CABG) was the leading Application in 2024
Based on end user segmentation, Large Hospitals were the leading end user in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Sternal Closure Systems Market is segmented on the basis of Product Type, Material, Fixation Type, Application, End User, and Region.
The market is divided into two categories based on product type: Closure Devices (Sternal Wires, Plates, Screws, Cables, Clips) and Bone Cement (PMMA (Polymethyl methacrylate), Biodegradable Cement). Closure devices dominate the sternal closure systems market, with sternal wires and plates widely preferred due to their clinical reliability and procedural familiarity. Among bone cements, PMMA holds greater usage than biodegradable options, though the latter is gaining interest for post-operative healing.
The market is divided into four categories based on Material: Titanium Alloys, Stainless Steel, PEEK (Polyether ether ketone), and Bioresorbable Polymers. Titanium alloys lead the material preference due to superior strength, corrosion resistance, and biocompatibility, especially in high-risk cardiac surgeries. Stainless steel remains widely used for cost-effective cases, while PEEK and bioresorbable polymers are gaining traction for minimally invasive and pediatric applications.
Sternal Closure Systems Market- Geographical Insights
In North America, the U.S. held the largest share in 2023-around 34-38% of global revenue-due to high volumes of open-heart surgeries (estimated at ~500,000 annually), advanced healthcare infrastructure, and active deployment of innovative closure solutions. Europe follows with robust growth, particularly in Germany, the UK, and France, where cardiothoracic procedures continue increasing and product innovation is encouraged-such as DePuy Synthes' collaboration with hospitals to integrate its advanced titanium-based systems. The Asia-Pacific region shows the fastest expansion, driven by rising geriatric populations in Japan and India, improving healthcare infrastructure, and government initiatives to expand surgical capacity. Meanwhile, strategic acquisitions-like A&E Medical's acquisition of RTI Surgical's sternal closure division (cable/plate products)-have helped players strengthen regional penetration and broaden product portfolios.
Major players such as DePuy Synthes (Johnson & Johnson), Zimmer Biomet, and KLS Martin Group lead the competitive landscape, holding approximately 65% of global market share through robust portfolios of wire, cable, and plate systems. In December 2020, Zimmer Biomet acquired A&E Medical Corporation, significantly expanding its sternal closure portfolio, including sutures, rigid fixation systems, and cable products. DePuy Synthes continues to assert its dominance with staple products like ZIPFIX and titanium fixation systems, backed by its strong presence in North America, Germany, and Canada. KLS Martin Group focuses on rigid fixation innovations such as anatomical locking plates and modular cable systems, leveraging German engineering for high-end procedures. Other notable players, including Stryker and B. Braun, are pursuing partnerships, technological innovation, and pricing strategies to contend with emerging domestic manufacturers in a cost-sensitive market.
In March 2025, Arthrex announced clinical results showing its FiberTape(R) sternal closure system reduced sternal dehiscence and infections compared to metal wires, while also lowering post-op pain and closure time, as published in the Journal of Clinical Medicine.
In August 2024, DePuy Synthes launched the MatrixSTERNUM Fixation System, offering enhanced chest stability after cardiac surgery with 3x locking strength, improved fixation workflow, and ultra-thin plates to support better healing following sternotomy procedures.
In January 2023, Abl Medical Devices launched its Valkyrie(R) Looped Sternotomy Sutures, stainless-steel looped wire sutures that double surface area and provide enhanced sternal closure strength, fitting multiple needle configurations and sizes without altering surgeons' preferred wiring techniques.